Neuro-imaging the serotonin 2A receptor as a valid biomarker for canine behavioural disorders

Research in Veterinary Science

Volumn 91, Issue 3, 2011, Pages 465-472

  Vermeire, Simon ^a   Audenaert, Kurt ^a   De Meester, Rudy ^a   Vandermeulen, Eva ^a   Waelbers, Tim ^a   De Spiegeleer, Bart ^a   Eersels, Jos ^b   Dobbeleir, André ^a   Peremans, Kathelijne ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anxiety; Brain imaging; Canine behaviour; Dog; Impulsive aggression; Serotonin 2A receptor; Single photon emission computed tomography

Indexed keywords

BIOLOGICAL MARKER; N,N'' 1,2 ETHYLENE DIYLBIS LEVO CYSTEINE DIETHYL ESTER TC 99M; R 91150; R 91150 I 123; RADIOPHARMACEUTICAL AGENT; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

AGGRESSION; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; BEHAVIOR DISORDER; BRAIN REGION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DOG; FEMALE; IMPULSIVENESS; IN VIVO STUDY; MALE; NEUROIMAGING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEIVER OPERATING CHARACTERISTIC; RECEPTOR BINDING; RECEPTOR DENSITY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

AGGRESSION; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; BRAIN; DOGS; RECEPTOR, SEROTONIN, 5-HT2A;

CANIS FAMILIARIS;

EID: 80555154383     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.09.021     Document Type: Article

References (74)

1. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Archives of General Psychiatry 1976, 33:1193-1197.
2. Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., van Heeringen C., Dierckx R.A. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. European Journal of Nuclear Medicine 2001, 28:175-182.
3. Audenaert K., Van Laeren K., Dumont F., Vervaet M., Goethals I., Slegers G., Mertens J., van Heeringen C., Dierckx R.A. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. Journal of Nuclear Medicine 2003, 44:163-169.
4. Audenaert K., Peremans K., Goethals I., van Heeringen C. Functional imaging, serotonin and the suicidal brain. Acta Neurologica Belgica 2006, 106:125-131.
5. Badino P., Odore R., Osella M.C., bergamasco L., Francone P., Girardi C., Re G. Modifications of serotonergic and adrenergic receptor concentrations in the brain of aggressive Canis familiaris. Comparative Biochemistry and Physiology Part A: Molecular; Integrative Physiology 2004, 139:343-350.
6. 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects. European Journal of Nuclear Medicine 1998, 25:1617-1622.
7. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. British Journal of Psychiatry 1997, 171:444-448.
8. Caldwell E.E., Miczek K.A. Long-term citalopram maintenance in mice: selective reduction of alcohol-heightened aggression. Psychopharmacology (Berlin) 2008, 196:407-416.
9. Carrasco G.A., van de Kar L.D., Jia C., Xu H., Chen Z., Chadda R., Garcia F., Muma N.A., Battaglia G. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo. Journal of Pharmacology and Experimental Therapeutics 2007, 320:1078-1086.
10. Case L.P. The Dog: Its Behavior, Nutrition, and Health 2005, Blackwell Publishing, Iowa, USA.
11. Doudet D., Hommer D., Higley J.D., Andreason P.J., Moneman R., Suomi S.J., Linnoila M. Cerebral glucose metabolism, CSF 5-HIAA levels, and aggressive behavior in rhesus monkeys. American Journal of Psychiatry 1995, 152:1782-1787.
12. Eersels J.L.H., Travis M.J., Herscheid J.D.M. Manufacturing i-123-labelled radiopharmaceuticals. Pitfalls and solutions. Journal of Labelled Compounds & Radiopharmaceuticals 2005, 48:241-257.
13. Eison A.S., Mullins U.L. Regulation of central 5-HT2A receptors: a review of in vivo studies. Behavioural Brain Research 1996, 73:177-181.
14. Enna S.J. Role of gamma-aminobutyric acid in anxiety. Psychopathology 1984, 17(Suppl. 1):15-24.
15. Eren I., Tukel R., Polat A., Karaman R., Unal S. Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. Psychiatry Research 2003, 123:135-143.
16. Esler M., Lambert E., Alvarenga M., Socratous F., Richards J., Barton D., Pier C., Brenchley C., Dawood T., Hastings J., Guo L., Haikerwal D., Kaye D., Jennings G., Kalff V., Kelly M., Wiesner G., Lambert G. Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress 2007, 10:295-304.
17. Fernandez M., Pissiota A., Frans O., von K.L., Fischer H., Fredrikson M. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study. Neuroscience Letters 2001, 297:101-104.
18. Frank G.K., Kaye W.H., Meltzer C.C., Price J.C., Greer P., McConaha C., Skovira K. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biological Psychiatry 2002, 52:896-906.
19. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., Svarer C., Hasselbalch S.G., Holm S., Paulson O.B., Knudsen G.M. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological Psychiatry 2008, 63:569-576.
20. Gross C., Santarelli L., Brunner D., Zhuang X., Hen R. Altered fear circuits in 5-HT(1A) receptor KO mice. Biological Psychiatry 2000, 48:1157-1163.
21. Gunther L., Liebscher S., Jahkel M., Oehler J. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice. European Journal of Pharmacology 2008, 593:49-61.
22. Haug L.I. Canine aggression toward unfamiliar people and dogs. Veterinary Clinics of North America: Small Animal Practice 2008, 38:1023-1041.
23. Hejjas K., Vas J., Topal J., Szantai E., Ronai Z., Szekely A., Kubinyi E., Horvath Z., Sasvari-Szekely M., Miklosi A. Association of polymorphisms in the dopamine D4 receptor gene and the activity-impulsivity endophenotype in dogs. Animal Genetics 2007, 38:629-633.
24. Higley J.D., Mehlman P.T., Higley S.B., Fernald B., Vickers J., Lindell S.G., Taub D.M., Suomi S.J., Linnoila M. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Archives of General Psychiatry 1996, 53:537-543.
25. Higley J.D., Mehlman P.T., Poland R.E., Taub D.M., Vickers J., Suomi S.J., Linnoila M. CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors. Biological Psychiatry 1996, 40:1067-1082.
26. Houpt K.A., Honig S.U., Reisner I.R. Breaking the human-companion animal bond. Journal of the American Veterinary Medical Association 1996, 208:1653-1659.
27. Hsu Y.Y., Serpell J.A. Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs. Journal of the American Veterinary Medical Association 2003, 223:1293-1300.
28. Ichise M., Golan H., Ballinger J.R., Vines D., Blackman A., Moldofsky H. Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects. Journal of Nuclear Medicine 1997, 38:1253-1260.
29. Inada Y., Yoneda H., Koh J., Sakai J., Himei A., Kinoshita Y., Akabame K., Hiraoka Y., Sakai T. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Research 2003, 118:25-31.
30. Kaye W.H., Frank G.K., Bailer U.F., Henry S.E., Meltzer C.C., Price J.C., Mathis C.A., Wagner A. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiology & Behavior 2005, 85:73-81.
31. Linnoila V.M., Virkkunen M. Aggression, suicidality, and serotonin. Journal of Clinical Psychiatry 1992, 53(Suppl.):46-51.
32. Mehlman P.T., Higley J.D., Faucher I., Lilly A.A., Taub D.M., Vickers J., Suomi S.J., Linnoila M. Low CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. American Journal of Psychiatry 1994, 151:1485-1491.
33. Meltzer C.C., Smith G., Price J.C., Reynolds C.F., Mathis C.A., Greer P., Lopresti B., Mintun M.A., Pollock B.G., Ben-Eliezer D., Cantwell M.N., Kaye W., DeKosky S.T. Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction. Brain Research 1998, 813:167-171.
34. Mertens J., Terriere D., Sipido V., Gommeren W., Janssen P.M.F., Leysen J.E. Radiosynthesis of a new radioiodinated ligand for serotonin-5Ht(2)-receptors, a promising tracer for gamma-emission tomography. Journal of Labelled Compounds & Radiopharmaceuticals 1994, 34:795-806.
35. Messa C., Colombo C., Moresco R.M., Gobbo C., Galli L., Lucignani G., Gilardi M.C., Rizzo G., Smeraldi E., Zanardi R., Artigas F., Fazio F. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berlin) 2003, 167:72-78.
36. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G.M., DaSilva J.N., Wilson A.A., Blak T., Eynan-Harvey R., Goulding V.S., Houle S., Links P. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. American Journal of Psychiatry 2003, 160:90-99.
37. Millan M.J. The neurobiology and control of anxious states. Progress in Neurobiology 2003, 70:83-244.
38. Mintun M.A., Sheline Y.I., Moerlein S.M., Vlassenko A.G., Huang Y., Snyder A.Z. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biological Psychiatry 2004, 55:217-224.
39. Miyata S., Shimoi T., Hirano S., Yamada N., Hata Y., Yoshikawa N., Ohsawa M., Kamei J. Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice. Journal of Pharmacological Sciences 2007, 105:272-278.
40. Moresco R.M., Pietra L., Henin M., Panzacchi A., Locatelli M., Bonaldi L., Carpinelli A., Gobbo C., Bellodi L., Perani D., Fazio F. Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naive patients. Neuropsychopharmacology 2007, 32:197-205.
41. Nic Dhonnchadha B.A., Bourin M., Hascoet M. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behavioural Brain Research 2003, 140:203-214.
42. Nic Dhonnchadha B.A., Hascoet M., Jolliet P., Bourin M. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice. Behavioural Brain Research 2003, 147:175-184.
43. Overall, K.L., 1997. Clinical Behavioral Medicine for Small Animals. Mosby, St-Louis.
44. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biological Psychiatry 2006, 59:106-113.
45. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience 1987, 21:123-139.
46. Perani D., Garibotto V., Gorini A., Moresco R.M., Henin M., Panzacchi A., Matarrese M., Carpinelli A., Bellodi L., Fazio F. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage 2008, 42:306-314.
47. Peremans K., De Bondt P., Audenaert K., Van Laere K., Gielen I., Koole M., Versijpt J., Van Bree H., Verschooten F., Dierckx R. Regional brain perfusion in 10 normal dogs measured using Technetium-99m ethyl cysteinate dimer spect. Veterinary Radiology & Ultrasound 2001, 42:562-568.
48. Peremans K., Audenaert K., Blanckaert P., Jacobs F., Coopman F., Verschooten F., Van Bree H., van Heeringen C., Mertens J., Slegers G., Dierckx R. Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002, 26:1393-1404.
49. 123I-5-I-R91150 in the normal dog. Nuclear Medicine Communications 2002, 23:1019-1027.
50. 123I-5-I-R91150. European Journal of Nuclear Medicine 2003, 30:1538-1546.
51. 123I-5-I-R91150 SPECT. European Journal of Nuclear Medicine 2005, 32:708-716.
52. 123I-5-I-R91150 and single-photon emission tomography before and after low-dose pipamperone administration in the canine brain. Nuclear Medicine Communications 2008, 29:724-729.
53. Reisner I.R., Mann J.J., Stanley M., Huang Y.Y., Houpt K.A. Comparison of cerebrospinal fluid monoamine metabolite levels in dominant-aggressive and non-aggressive dogs. Brain Research 1996, 714:57-64.
54. Rosier A., Dupont P., Peuskens J., Bormans G., Vandenberghe R., Maes M., de G.T., Schiepers C., Verbruggen A., Mortelmans L. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging. Psychiatry Research 1996, 68:11-22.
55. Roy C.S., Sherrington C.S. On the Regulation of the blood-supply of the brain. Journal of Physiology 1890, 11:85-158.
56. Seibert L.M., Landsberg G.M. Diagnosis and management of patients presenting with behavior problems. Veterinary Clinics of North America: Small Animal Practice 2008, 38:937-950.
57. Seo D., Patrick C.J., Kennealy P.J. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggression and Violent Behavior 2008, 13:383-395.
58. Sherman B.L., Mills D.S. Canine anxieties and phobias: an update on separation anxiety and noise aversions. Veterinary Clinics of North America: Small Animal Practice 2008, 38:1081-1086.
59. Siever L., Insel T., Uhde T. Noradrenergic challenges in the affective disorders. Journal of Clinical Psychopharmacology 1981, 1:193-206.
60. Soloff P.H., Price J.C., Meltzer C.C., Fabio A., Frank G.K., Kaye W.H. 5HT2A receptor binding is increased in borderline personality disorder. Biological Psychiatry 2007, 62:580-587.
61. Soloff P.H., Price J.C., Mason N.S., Becker C., Meltzer C.C. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Research 2010, 181:77-84.
62. Stein, D.J., Ipser, J.C., Balkom, A.J., 2000. Pharmacotherapy for social anxiety disorder. Cochrane Database of Systematic Reviews CD001206.
63. Sullivan G.M., Oquendo M.A., Huang Y.Y., Mann J.J. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. International Journal of Neuropsychopharmacology 2006, 9:547-556.
64. Sullivan G.M., Ogden R.T., Oquendo M.A., Kumar J.S., Simpson N., Huang Y.Y., Mann J.J., Parsey R.V. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biological Psychiatry 2009, 66:223-230.
65. Unschuld P.G., Ising M., Erhardt A., Lucae S., Kloiber S., Kohli M., Salyakina D., Welt T., Kern N., Lieb R., Uhr M., Binder E.B., Muller-Myhsok B., Holsboer F., Keck M.E. Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007, 144:424-429.
66. Vage J., Lingaas F. Single nucleotide polymorphisms (SNPs) in coding regions of canine dopamine- and serotonin-related genes. BMC Genetics 2008, 9:10.
67. Van Oekelen D., Luyten W.H., Leysen J.E. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Science 2003, 72:2429-2449.
68. 123I-5I-R91150 and SPECT. Journal of Nuclear Medicine 2009, 50:284-289.
69. Vermeire, S., Audenaert, K., Dobbeleir, A., Vandermeulen, E., Waelbers, T., Peremans, K., 2010. A Cavalier King Charles dog with shadow chasing: Clinical recovery and normalization of the dopamine transporter binding after clomipramine treatment. Journal of Veterinary Behavior-Clinical Applications and Research Res., in press.
70. Volavka J. The neurobiology of violence: an update. Journal of Neuropsychiatry and Clinical Neurosciences 1999, 11:307-314.
71. Walovitch R.C., Cheesman E.H., Maheu L.J., Hall K.M. Studies of the retention mechanism of the brain perfusion imaging agent 99mTc-bicisate (99mTc-ECD). Journal of Cerebral Blood Flow & Metabolism 1994, 14(Suppl. 1):S4-S11.
72. Westenberg H.G., Liebowitz M.R. Overview of panic and social anxiety disorders. Journal of Clinical Psychiatry 2004, 65(Suppl. 14):22-26.
73. Wolff M.C., Leander J.D. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 2002, 27:421-429.
74. Zanardi R., Artigas F., Moresco R., Colombo C., Messa C., Gobbo C., Smeraldi E., Fazio F. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. Journal of Clinical Psychopharmacology 2001, 21:53-58.